September Webinar: Understanding Head & Neck cancer late effects in survivorship.
We're delighted to announce our upcoming Late Effects webinar, bringing together leading clinical expertise and lived experience to explore the long-term impact of head and neck cancer treatment.
Webinar
From Cure to Consequence: Understanding Head and Neck cancer late effects in survivorship
Thursday 10 September 2026
18:00 - 19:00
Please note webinars are recorded for later use on our website and social media channels. If you'd rather not be recorded, you are welcome to turn your camera off, use a nickname on screen instead of your real name, and make use of the chat function to ask questions.
Sabina Khan and Emma Hallam, Macmillan Consultant Radiographers
Sabina Khan (University College London) and Emma Hallam (Nottingham University Hospitals) will be our clinical speakers for the webinar. Both are specialists in head and neck post-treatment and late effects, and are currently producing a detailed guidance document on late effects radiotherapy best practice for clinicians.
Emma Hallam is a Consultant Radiographer, clinical leader and educator specialising in cancer survivorship and the management of treatment-related consequences. In 2013, she established the award-winning Macmillan Nottingham Radiotherapy Late Effects Clinic, the first dedicated service of its kind in the UK, providing holistic support for patients experiencing the complex physical and psychological effects of cancer treatment. Her clinical and research interests focus on Radiation-Induced Fibrosis (RIF) and the innovative use of Photobiomodulation (PBM) therapy to improve outcomes for those living with long-term treatment consequences. Through clinical practice, research, education and national service development, Emma is passionate about breaking down barriers to care and ensuring patients are supported not only to survive cancer, but to live well beyond it.
Sabina Khan has over a decade of specialist experience in head and neck cancer, working across radiotherapy, proton beam therapy, and survivorship. She leads the first UK therapeutic radiographer-led head and neck late effects service, reshaping how long-term care is delivered. She is passionate about questioning the traditional definitions of survivorship by providing more personalised and equitable care. Sabina's work highlights the disparities faced by marginalised groups, ensuring that innovation in head and neck oncology is grounded in compassion, curiosity, and a commitment to meaningful change.
Karen Liesching-Schroder, Oracle Voice and patient speaker
Oracle launches new webinar series to support Head & Neck Cancer Patients
Oracle Head & Neck Cancer has launched its new webinar series for anyone newly diagnosed with head and neck cancer. First in the series ‘I’ve just been diagnosed. What now?” features retired Consultant Oncologist Professor Dr Mehmet Sen and patient speaker Hazel Turner. They share expert advice and personal experience to help patients and…
Newsletter June 2026
Julie Child, Executive Director It’s been a whirlwind five months since I started at Oracle Head and Neck Cancer UK. Thanks to your support and donations, the charity was successful in its Emergency Appeal and managed to secure the funds required to go forward. I’ve been very fortunate to meet a number of supporters, both…
Using the power of football to help prevent cancer
This week, Oracle Head & Neck Cancer UK has launched an important awareness campaign in partnership with Bromley FC, using the reach of football to shine a light on head and neck cancer prevention and the life-saving importance of the HPV vaccine. Throughout the week, Bromley FC is sharing trusted health information with its supporters,…
Cancer Care: Why Mental Health Support Must Be Part of Every Cancer Journey
Oracle Head & Neck Cancer UK is proud to support the Daily Express Cancer Care campaign, a powerful series that shines a light on the often unseen emotional toll of cancer – and the urgent need for better psychological support for everyone affected. The campaign published over the past three weeks featured voices from across…
Ground-breaking blood test shows promise for early detection of head & neck and other hard-to-screen cancers
A new large-scale trial has found that the blood-based screening test known as Galleri test can detect more than 50 types of cancer – including cancers of the head and neck, which currently have no routine screening programme – and may significantly boost early diagnosis. The trial showed that, when used alongside existing screening methods,…
2 Minutes to Save Your Life: Oracle Launches HeadNeckCheck Campaign for Make Sense Week
This Make Sense Week (15-20 September), the European-wide head and neck cancer awareness initiative, Oracle Head & Neck Cancer UK, is championing both prevention and early detection – recognising that stopping cancer before it starts is just as vital as catching it early. Two Ways to Fight Cancer This Week Prevention Today: Head and neck…
Finding Light in Adversity: Seven inspiring stories through head and neck cancer
A new collection of patient stories from Oracle Head and Neck Cancer UK reveals how individuals facing head and neck cancer have discovered unexpected sources of strength, purpose and even joy during their treatment and recovery. The seven contributors share remarkably similar themes despite their unique journeys. Almost all emphasise the power of maintaining a…
NHS to fast-track patients with head and neck cancer into cancer vaccine trial
Patients with advanced head and neck cancers in England will be fast-tracked into a trial of a new cancer vaccine, as the NHS expands its world-leading trial ‘match-making’ service. The investigational cancer vaccine uses mRNA technology to help the immune system recognise and kill cancer cells containing human papillomavirus proteins. More than 100 patients with advanced head…
World Head and Neck Cancer Awareness Day 2025: The HPV Vaccine Could Save Your Life
27th July 2025 This World Head and Neck Cancer Awareness Day, Oracle Head and Neck Cancer UK has a simple but urgent message: HPV vaccination saves lives. With HPV-related head and neck cancers having doubled in the past 20 years, the charity is using today to remind the public that these devastating cancers are preventable…
Data from the National Disease Registration Service on HPV associated and HPV independent oropharyngeal squamous cell carcinoma
The Get Data Out Programme from the National Disease Registration Service (NDRS), part of NHS England, has published statistics on incidence, routes to diagnosis and treatment for patients diagnosed with oropharyngeal cancer in England by human papillomavirus (HPV) status. To our knowledge this is the first time data on oropharyngeal cancer by HPV status has…
Help Beat Head and Neck Cancer
Oracle Head & Neck Cancer UK is a registered charity in England and Wales (1142037), and in Scotland (SC052790).
Registered as a company limited by guarantee in England and Wales (7125497). Registered address: 167-169, Great Portland Street, 5th Floor, London W1W 5PF.